E2F5 is a transcriptional activator that binds E2F consensus sites in gene promoters to regulate cell proliferation and differentiation. As a member of the E2F family of transcription factors, E2F5 functions primarily as a cell cycle regulator, controlling genes essential for proliferation 1. Beyond proliferation control, E2F5 plays a specialized role in multiciliated cell differentiation, where it cooperates with MCIDAS to activate genes required for centriole biogenesis 2. In developmental contexts, E2F5 exhibits dynamic regulation; its protein expression decreases late in embryogenesis with concurrent cytoplasmic relocalization in choroid plexus epithelium, coinciding with epithelial maturation rather than proliferation 3. E2F5 serves dual oncogenic and tumor suppressive roles depending on context. Overexpression promotes transformation in cooperation with activated RAS 1, with amplification detected in breast tumors 1. Conversely, E2F5 loss in mammary tissue unexpectedly leads to metastatic tumor development through Cyclin D1 dysregulation, revealing tumor suppressor functions 4. In prostate and gastric cancers, E2F5 exhibits pro-tumorigenic activity by directly activating invasion-associated genes including MMP-2, MMP-9, and UBE2T 5 6. E2F5 dysregulation also promotes retinoblastoma progression 7. These findings establish E2F5 as a context-dependent transcriptional regulator with distinct roles in developmental processes and malignant transformation.